As of April 19, 2025, Molecular Partners (MOLN) has a market cap of $0.15 billion USD. According to our data, Molecular Partners is ranked No.7278 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $0.15 B |
-16.36%
|
Dec 31, 2024 | $0.18 B |
13.59%
|
Dec 29, 2023 | $0.15 B |
-36.18%
|
Dec 30, 2022 | $0.24 B |
-65.85%
|
Dec 31, 2021 | $0.71 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
![]() UK
|
![]() GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
![]() UK
|
![]() Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
![]() USA
|
Market Cap | = | MOLN Stock Price | * | MOLN Shares Outstanding |
= | $3.97 | * | 36.87 M | |
= | $0.15 B |